Zhejiang Medicine Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 2.04%

Zhejiang Medicine Co Ltd (600216) has an Asset Resilience Ratio of 2.04% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 600216 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥288.33 Million

≈ $42.19 Million USD Cash + Short-term Investments

Total Assets

CN¥14.14 Billion

≈ $2.07 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2001–2024)

This chart shows how Zhejiang Medicine Co Ltd's Asset Resilience Ratio has changed over time. See what is Zhejiang Medicine Co Ltd's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Medicine Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zhejiang Medicine Co Ltd market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥288.33 Million	2.04%
Total Liquid Assets	CN¥288.33 Million	2.04%

Asset Resilience Insights

Limited Liquidity: Zhejiang Medicine Co Ltd maintains only 2.04% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Medicine Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Medicine Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Yabao Pharmaceutical Group Co Ltd SHG:600351	Drug Manufacturers - Specialty & Generic	0.27%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	6.43%
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	6.40%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Annual Asset Resilience Ratio for Zhejiang Medicine Co Ltd (2001–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Medicine Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.14%	CN¥294.91 Million ≈ $43.15 Million	CN¥13.80 Billion ≈ $2.02 Billion	-0.43pp
2023-12-31	2.57%	CN¥328.31 Million ≈ $48.04 Million	CN¥12.78 Billion ≈ $1.87 Billion	-1.03pp
2022-12-31	3.60%	CN¥447.29 Million ≈ $65.45 Million	CN¥12.43 Billion ≈ $1.82 Billion	-0.03pp
2021-12-31	3.63%	CN¥454.40 Million ≈ $66.49 Million	CN¥12.53 Billion ≈ $1.83 Billion	+1.05pp
2020-12-31	2.58%	CN¥270.73 Million ≈ $39.62 Million	CN¥10.50 Billion ≈ $1.54 Billion	-0.59pp
2019-12-31	3.17%	CN¥328.63 Million ≈ $48.09 Million	CN¥10.36 Billion ≈ $1.52 Billion	+3.08pp
2018-12-31	0.09%	CN¥8.68 Million ≈ $1.27 Million	CN¥10.05 Billion ≈ $1.47 Billion	+0.08pp
2017-12-31	0.01%	CN¥778.05K ≈ $113.85K	CN¥9.79 Billion ≈ $1.43 Billion	0.00pp
2013-12-31	0.01%	CN¥670.65K ≈ $98.14K	CN¥7.56 Billion ≈ $1.11 Billion	0.00pp
2012-12-31	0.01%	CN¥891.75K ≈ $130.49K	CN¥7.06 Billion ≈ $1.03 Billion	+0.00pp
2010-12-31	0.01%	CN¥570.00K ≈ $83.41K	CN¥4.64 Billion ≈ $678.56 Million	-0.08pp
2006-12-31	0.09%	CN¥2.25 Million ≈ $329.25K	CN¥2.53 Billion ≈ $369.98 Million	+0.05pp
2005-12-31	0.04%	CN¥898.23K ≈ $131.44K	CN¥2.21 Billion ≈ $323.07 Million	-0.02pp
2004-12-31	0.06%	CN¥1.17 Million ≈ $171.50K	CN¥1.84 Billion ≈ $269.09 Million	-0.12pp
2002-12-31	0.19%	CN¥3.06 Million ≈ $447.34K	CN¥1.64 Billion ≈ $239.50 Million	+0.06pp
2001-12-31	0.13%	CN¥2.00 Million ≈ $292.66K	CN¥1.57 Billion ≈ $229.03 Million	--

pp = percentage points

About Zhejiang Medicine Co Ltd

SHG:600216 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.05 Billion

CN¥13.98 Billion CNY

Market Cap Rank

#6172 Global

#1340 in China

Share Price

CN¥14.54

Change (1 day)

-1.09%

52-Week Range

CN¥13.33 - CN¥18.38

All Time High

CN¥20.16